Valcon Medical A/S: Financial statements 2020
CVR: 40086714
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Valcon Medical A/S (CVR 40086714) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -1,132,718 and a net result of DKK -3,518,179 compared with DKK -4,344,377 the year before. Equity in the 2020 report amounted to DKK 639,542. The solvency ratio was 2%. The company had 8 employees in the financial year.
- Gross Profit
- DKK -1,132,718
- Profit/Loss
- DKK -3,518,179
- Equity
- DKK 639,542
- Total Assets
- DKK 32,539,791
- Employees
- 8
Official annual report
How creditworthy is Valcon Medical A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 11, 2020, Farzad Jahanshahi has left the board of directors of Valcon Medical A/S.
Valcon Medical A/S has published its annual report for 2019. Gross profit came to DKK -3,020,603, and the net result was DKK -4,344,377.
As of April 30, 2020, William Muecke has joined the board of directors of Valcon Medical A/S.
About Valcon Medical A/S
Valcon Medical A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 2018. The company is registered under the industry Fremstilling af andre organiske basiskemikalier. The company was previously named Aureum A/S. The management consists of Peter Emil Guldmann Sigetty. The board consists of Alex Sung Kwon (chair), Douglas Fischer, Ruchir Ashok Kadakia and William Muecke. The company is owned by BTS DK ApS. The company has 15 employees (2026). In 2025, the company reported a gross profit of DKK 2,139,839 and a net result of DKK -11,198,587 compared with EUR -41,728,331 the year before. Equity in the 2025 report amounted to DKK 11,420,803.
